Page last updated: 2024-08-05 11:33:00

anabolic androgenic steroid

A steroid hormone related to the hormone testosterone. It increases protein synthesis within cells, which results in the buildup of cellular tissue (anabolism), especially in muscles. It also has androgenic and virilizing properties.

ChEBI ID: 50786

Members (8)

MemberDefinitionRole
1-testosteroneAn anabolic steroid that differs from testosterone by having a 1,2-double bond instead of a 4,5-double bond in its A ring. A potent androgen with anabolic properties, it was legally sold as a prohormone in the U.S.A. until 2005, when it was reclassified as a Schedule III drug.Delta(1)-dihydrotestosterone
boldenoneAn 3-oxo-Delta(1),Delta(4)-steroid substituted by an oxo group at position 3 and a beta-hydroxy group at position 17. It is an anabolic androgenic steroid that has been developed for veterinary use.boldenone
dromostanolonemetholone
fluoxymesteronefluoxymesterone
metriboloneA synthetic non-aromatisable androgen and anabolic steroid. It binds strongly to the androgen receptor and has therefore also been used as an affinity label for this receptor in the prostate and in prostatic tumors.17beta-hydroxy-17-methylestra-4,9,11-trien-3-one
nandroloneA 3-oxo Delta(4)-steroid that is estr-4-en-3-one substituted by a beta-hydroxy group at position 17.nandrolone
oxandroloneoxandrolone
stanozololAn organic heteropentacyclic compound resulting from the formal condensation of the 3-keto-aldehyde moiety of oxymetholone with hydrazine. Like oxymetholone, it is a synthetic anabolic steroid. It has both anabolic and androgenic properties, and has been used to treat hereditary angioedema and various vascular disorders. It has also been widely abused by professional athletes.stanozolol

Research

Studies (4,943)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19902,374 (48.03)18.7374
1990's765 (15.48)18.2507
2000's860 (17.40)29.6817
2010's768 (15.54)24.3611
2020's176 (3.56)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials575 (10.52%)5.53%
Reviews273 (4.99%)6.00%
Case Studies299 (5.47%)4.05%
Observational15 (0.27%)0.25%
Other4,306 (78.75%)84.16%